13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-05, with 37 holding rows worth $446,954,000.
- Accession
- 0001567619-22-015003
- Filer
- CIK 1475373
- Filed
- 2022-08-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 37 entries on the cover page, a total value of $446,954,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $446,954,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 843,427 | $52,132,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 414,338 | $37,775,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 459,429 | $34,903,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 290,521 | $26,074,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 311,696 | $24,001,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 385,988 | $20,176,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 532,735 | $19,855,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 92,497 | $18,864,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 66,283 | $17,467,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 34,300 | $16,552,000 | thousands by filing date | |
| BRUKER CORP | 116794108 | COM | 251,042 | $15,755,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 168,111 | $15,577,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 181,799 | $15,382,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 135,749 | $14,262,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 247,502 | $12,167,000 | thousands by filing date | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 356,089 | $12,018,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 201,729 | $9,522,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 33,474 | $9,433,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 50,795 | $8,988,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 105,259 | $8,723,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 42,844 | $6,249,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 165,439 | $6,125,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 11,785 | $5,834,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 49,205 | $5,346,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 100,000 | $5,243,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 80,843 | $4,615,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 118,476 | $3,827,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 84,864 | $3,400,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 55,324 | $2,845,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 110,223 | $2,807,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 46,221 | $2,758,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 27,077 | $2,727,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,466,678 | $1,657,000 | thousands by filing date | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 88,670 | $1,436,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 301,224 | $1,362,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 123,713 | $964,000 | thousands by filing date | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 5,246 | $133,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-22-015003 | this filing | 2022-08-05 | acceptance time not in the bulk data set |